ProfileGDS5822 / ILMN_2577493
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 33% 46% 41% 42% 66% 56% 1% 15% 21% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.333
GSM1276600PDAC Late Ablation Control 222.346
GSM1276601PDAC Late Ablation Control 314.741
GSM1276602PDAC Late Ablation 116.642
GSM1276603PDAC Late Ablation 241.166
GSM1276604PDAC Late Ablation 328.956
GSM1303940PDAC Late Ablation_anti-CTLA4 13.61
GSM1303941PDAC Late Ablation_anti-CTLA4 28.815
GSM1303942PDAC Late Ablation_anti-CTLA4 310.821